The purpose of this study is to understand the impacts of regular consumption of freeze-dried table grape powder on eye health and regulation of advanced glycation end products in Singapore older adults. The investigators hypothesize that regular consumption of freeze-dried table grape powder will promote improvements in eye health and lower levels of advanced glycation end products when compared to the placebo group.
The study will be a 16-week, double-blind, randomized, placebo-controlled trial using a parallel study design. 46 adults (aged 60 - 85) will be recruited and randomly assigned to the intervention or placebo group to investigate whether regular consumption of freeze-dried table grape powder (46g/d) can improve eye health parameters, blood/skin AGE and glycemic status, and reduce inflammation and oxidative stress. This study will consist of 1 screening visit and 5 study visits with 4-week intervals.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
46
Consumption of grape powder as part of daily diet
Consumption of placebo grape powder as part of daily diet
National University of Singapore, Faculty of Science, Department of Food Science and Technology
Singapore, Singapore, Singapore
RECRUITINGMacular pigment optical density
A measurement of macular pigment of the eye using a heterochromatic flicker photometry device. The measurements are in arbitrary units.
Time frame: Week 0, Week 4, Week 8, Week 12, Week 16
Visual acuity
Participants will read out letters on a ETDRS LogMAR chart at a fixed distance where letters becomes smaller as it goes down the chart. Tests results will be recorded in number of letters read, where the more letters the better the outcome.
Time frame: Week 0, Week 4, Week 8, Week 12, Week 16
Photostress recovery time
An ophthalmoscope will be used to shine a light into the participants eye for 10 seconds, and participants will be required to read letters off a chart the moment their vision returns to normal. The faster the recovery time, the better the outcome. Units will be in seconds
Time frame: Week 0, Week 4, Week 8, Week 12, Week 16
Visual function questionnaire 25
A questionnaire to for participants to self-evaluate their perception of their current eye health based on general vision, ocular pain, near activities, distance activities, vision specific functions, driving, color vision and peripheral vision. The best possible score is 100 and worst possible score is 0.
Time frame: Week 0, Week 4, Week 8, Week 12, Week 16
Skin advanced glycation end products levels
Measurement of skin advanced glycation end products level using a skin autofluorescence device, where participants wlll be instructed to place their forearm over the device and a light will be shone and a reading can be captured by detecting fluorescence. The results will be presented as arbitrary units.
Time frame: Week 0, Week 4, Week 8, Week 12, Week 16
Dietary advanced glycation end products level
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Participants will be instructed to record down 3-day food records, from Thursday to Saturday, before each clinical visit. This will be used to estimate their advanced glycation end products intake from food by referring to existing nutrient databases. Units will be based on a common advanced glycation end product measured, carboxymethyllysine (CML), thus the unit will be mg CML/ kg food
Time frame: Week 0, Week 4, Week 8, Week 12, Week 16
Blood advanced glycation end products levels
Participants will have their blood drawn by medical professionals at the Occupational Health Clinic. The blood will be processed and stored. Measurements will be done using ultra-performance liquid chromatography coupled with mass spectrometry techniques to determine the levels of advanced glycation end products. Units will be in μg/mL.
Time frame: Week 0, Week 8 and Week 16
Contrast sensitivity
Participants will read out letters on a ETDRS LogMAR chart at a fixed distance, where the letters differs in lightness to test participants' sensitivity to contrast. Tests results will be recorded in number of letters read, where the more letters the better the outcome.
Time frame: Week 0, Week 4, Week 8, Week 12, Week 16
Concentration of tumour necrosis factor-α
The blood obtained from the participants will be processed for storage. Tumor necrosis factor-α results will be presented in ng/L according to the commercially available enzyme-linked immunosorbent assay kits.
Time frame: Week 0, Week 8, Week 16
Concentration of interleukin-6
The blood obtained from the participants will be processed for storage. Interleukin-6 results will be presented in ng/L according to the commercially available enzyme-linked immunosorbent assay kits.
Time frame: Week 0, Week 8, Week 16
Concentration of high-sensitivity C-reactive protein
The blood obtained from the participants will be processed for storage. Analyses of inflammation markers include tumor necrosis factor-α, interleukin-6. high sensitivity C-reactive protein. Tumor necrosis factor-α and interleukin-6 results will be presented in ng/L according to the commercially available enzyme-linked immunosorbent assay kits. High-sensitivity C-reactive protein results will be obtained and presented in mg/L by commercial lab testing.
Time frame: Week 0, Week 8, Week 16
Concentration of fasting blood glucose
Fasting blood glucose will be measured using commercial lab testing using participants' blood, units will be in mmol/L.
Time frame: Week 0, Week 8, Week 16
Concentration of malondialdehyde
The blood obtained from the participants will be processed for storage. Analyses of malondialdehyde using commercially available enzyme-linked immunosorbent assay kits. Units for malondialdehyde will be in ng/L according to assay kit instructions.
Time frame: Week 0, Week 8, Week 16
Concentration of 8-isoprostaglandin-F2α
The blood obtained from the participants will be processed for storage. Analyses of 8-isoprostaglandin-F2α using commercially available enzyme-linked immunosorbent assay kits. Units for 8-isoprostaglandin-F2α will be in µmol/L according to assay kit instructions.
Time frame: Week 0, Week 8, Week 16
Skin carotenoid status
Measured using a commercially available device that measured carotenoids using Raman spectroscopy. Results are in arbitrary units.
Time frame: Week 0, Week 4, Week 8, Week 12, Week 16;
Concentration of insulin
Fasting blood insulin will be measured using commercial lab testing using participants' blood, units in μU/L.
Time frame: Week 0, Week 8, Week 16
Percentage of glycated hemoglobin
Glycated hemoglobin will be measured using commercial lab testing from participant's blood, units in percent.
Time frame: Week 0, Week 8, Week 16